PGIM Jennison Health Sciences Fund's Q2 2024 investor letter discussed stock performance, highlighting Amgen Inc. (NASDAQ:AMGN). The fund noted Amgen's one-month return and market capitalization. They mentioned the potential of AI stocks for higher returns compared to Amgen.